title: Standard addition analysis of fluoroquinolones in human serum in the presence of the interferent salicylate using lanthanide-sensitized excitation-time decay luminescence data and multivariate curve resolution.
abstract: Three fluoroquinolone antibiotics (ciprofloxacin, norfloxacin and danofloxacin) have been determined in human serum in the presence of the potential interferent salicylate, by processing lanthanide-sensitized excitation-time decay matrix data for their terbium (III) complexes. The algorithm employed, multivariate curve resolution-alternating least-squares, is one of the few methodologies which permit the achievement of the second-order advantage in the presence of a high degree of overlapping between the time decay profiles for the analyte and the interferent complexes. Furthermore, the presence of analyte-background interactions makes it necessary to employ the standard addition method for successful quantitation. Both simulations and experiments showed that the modified standard addition method was suitable for this purpose, in which the test data matrix was subtracted from the standard addition matrices, and quantitation proceeded using classical external calibration procedure. The analyte concentration ranges were all within the therapeutic range, i.e., 0-6 mgL(-1) in serum, with final concentrations in the measuring cell in the order of 0.2 mgL(-1).
authors.affiliation: Departamento de Química Analítica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario and Instituto de Química Rosario (IQUIR-CONICET), Suipacha 531, Rosario (S2002LRK), Argentina.
authors.forename: Valeria A
authors.initials: VA
authors.lastname: Lozano
authors.forename: Romà
authors.initials: R
authors.lastname: Tauler
authors.forename: Gabriela A
authors.initials: GA
authors.lastname: Ibañez
authors.forename: Alejandro C
authors.initials: AC
authors.lastname: Olivieri
mesh_terms: D000900:Anti-Bacterial Agents / Q000097:blood; D002939:Ciprofloxacin; D024841:Fluoroquinolones / Q000097:blood*; D006801:Humans; D028581:Lanthanoid Series Elements; D008163:Luminescent Measurements / Q000379:methods*; D009643:Norfloxacin; D012459:Salicylates / Q000097:blood*; D013725:Terbium
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D028581:Lanthanoid Series Elements; D012459:Salicylates; D013725:Terbium; C068581:danofloxacin; D002939:Ciprofloxacin; D009643:Norfloxacin